Share Price | Oscar Health, Inc. Stock Analysis & Recommendation

Q: How big is Oscar Health, Inc.?

Market Cap: As of Jun 18, Oscar Health, Inc. has a market capitalization of 4,107.92 million, classifying it as a Small Cap company.Recent Quarterly Performance: For the latest four quarters, Oscar Health, Inc. reported net sales of 0.00 million and a net profit of 124.15 million.Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 1,013.59 million, while total assets were reported at 4,548.96 million.

Q: What does Oscar Health, Inc. do?

Overview:Oscar Health, Inc. operates in the Healthcare Services industry and is classified as a small-cap company.Financial Snapshot:- Net Profit: 276 Million (Quarterly Results - Mar 2025)- Market Cap: USD 4,107.92 Million (Small Cap)Key Metrics:- P/E: 32.00- Dividend Yield: 0.00%- Debt Equity: -2.02- Return on Equity: 9.31%- Price to Book: 3.08Contact Details:No Company Details Available.

Q: Is Oscar Health, Inc. overvalued or undervalued?

As of 6 August 2025, the valuation grade for Oscar Health, Inc. has moved from fair to risky, indicating a shift in perception regarding its financial health and market position. The company appears to be overvalued, particularly when considering its high P/E ratio of 32 and an EV to EBITDA ratio of 40.04, which are significantly above industry norms, as evidenced by peers such as Molina Healthcare, Inc. with a P/E of 8.42 and an EV to EBITDA of 20.30.In addition, Oscar Health's PEG ratio of 0.10 suggests that its growth prospects may not justify its current valuation. The company has also underperformed compared to the S&P 500 over the past year, with a stock return of -15.44% versus the index's 17.14%, although it has shown impressive growth over the past three years with a return of 232.93% compared to the S&P 500's 70.41%. This mixed performance further reinforces the notion that Oscar Health is currently overvalued in the market.

Q: Is Oscar Health, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Oscar Health, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly timeframes, and Bollinger Bands are also bullish in the same periods. Daily moving averages confirm a bullish trend as well. However, the KST is mildly bearish on a monthly basis, and the OBV shows mild bearishness on both weekly and monthly timeframes, indicating some caution. In terms of performance, Oscar Health has significantly outperformed the S&P 500 with a year-to-date return of 66.0% compared to the S&P 500's 14.18%, and an impressive 369.68% return over the past three years versus the S&P 500's 82.57%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.03 M

Shareholding (Dec 2025)

FII

8.16%

Held by 140 FIIs

DII

48.7%

Held by 53 DIIs

Promoter

11.00%

How big is Oscar Health, Inc.?

22-Jun-2025

As of Jun 18, Oscar Health, Inc. has a market capitalization of $4.11 billion and reported net sales of $0.00 million with a net profit of $124.15 million over the latest four quarters. The company's shareholder's funds were $1.01 billion, and total assets amounted to $4.55 billion as of Dec 24.

View full answer

What does Oscar Health, Inc. do?

22-Jun-2025

Oscar Health, Inc. is a small-cap company in the Healthcare Services industry, with a market cap of approximately $4.1 billion and a net profit of $276 million as of March 2025. Key metrics include a P/E ratio of 32.00 and a return on equity of 9.31%.

View full answer

Is Oscar Health, Inc. overvalued or undervalued?

20-Sep-2025

As of August 6, 2025, Oscar Health, Inc. is considered overvalued with a risky valuation grade, reflected by its high P/E ratio of 32 and EV to EBITDA ratio of 40.04, despite impressive three-year growth, as it has underperformed the S&P 500 over the past year.

View full answer

Is Oscar Health, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Oscar Health, Inc. is in a bullish trend with strong indicators, despite some caution from the KST and OBV, and has outperformed the S&P 500 with a year-to-date return of 66.0% compared to 14.18%.

View full answer

Compare Oscar Health, Inc. with Similar Stocks

Alignment Healthcare, Inc.Molina Healthcare, Inc.Centene Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company has declared negative results in Jan 70 after 9 consecutive negative quarters

OPERATING PROFIT(Q) Lowest at USD -230.48 MM
OPERATING PROFIT MARGIN(Q) Lowest at -8.05 %
PRE-TAX PROFIT(Q) Lowest at USD -233.54 MM

Risky - Negative Operating Profits

Mojo Parameters

Stock DNA

Industry

Healthcare Services

Market cap

USD 4,096 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-3.64

Return on Equity

-45.30%

Price to Book

4.19

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

-352 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.53%

6 Months

-13.36%

1 Year

-17.67%

2 Years

-24.4%

3 Years

136.25%

4 Years

89.0%

5 Years

0.0%

Oscar Health, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

90.80%

EBIT Growth (5y)

-286.13%

EBIT to Interest (avg)

-0.20

Debt to EBITDA (avg)

11.31

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

6.08

Tax Ratio

13.28%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

92.58%

ROCE (avg)

ROE (avg)

1.86%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.51

EV to EBIT

EV to EBITDA

65.29

EV to Capital Employed

-0.96

EV to Sales

0.19

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-13.87%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 66 Schemes (32.14%)

Foreign Institutions

Held by 140 Foreign Institutions (8.16%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -129.88% vs -2.34% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.90",
          "val2": "9.20",
          "chgp": "-14.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "-1.10",
          "val2": "6.00",
          "chgp": "-118.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-352.40",
          "val2": "-153.30",
          "chgp": "-129.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-119.00%",
          "val2": "-61.70%",
          "chgp": "-5.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1,796.93% vs 109.65% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.90",
          "val2": "32.10",
          "chgp": "-9.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.60",
          "val2": "23.70",
          "chgp": "-25.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-442.90",
          "val2": "26.10",
          "chgp": "-1,796.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-33.90%",
          "val2": "6.20%",
          "chgp": "-4.01%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

7.90

9.20

-14.13%

Interest

-1.10

6.00

-118.33%

Exceptional Items

0.00

Consolidate Net Profit

-352.40

-153.30

-129.88%

Operating Profit Margin (Excl OI)

-119.00%

-61.70%

-5.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -129.88% vs -2.34% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

28.90

32.10

-9.97%

Interest

17.60

23.70

-25.74%

Exceptional Items

0.00

Consolidate Net Profit

-442.90

26.10

-1,796.93%

Operating Profit Margin (Excl OI)

-33.90%

6.20%

-4.01%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -1,796.93% vs 109.65% in Dec 2024

All Annual Results

Company CV

About Oscar Health, Inc.

Oscar Health, Inc.

Healthcare Services

No Details Available.

Company Coordinates

No Company Details Available